Difference between revisions of "Fibrinogen gamma chain (TG2)"
m |
|||
| Line 45: | Line 45: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | Q145, Q195, Q239, Q311 are minor substrate sites | + | | Q145, Q195, Q239, Q311 are minor substrate sites considering modification by TG2 |
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 10:43, 23 July 2007
| Template:Infobox header| Fibrinogen gamma chain (TG2) | |
|---|---|
| Fibrinogen gamma chain (TG2) | |
| Substrate peptide name | Fibrinogen gamma chain (TG2) |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P02679 |
| Reactive glutamines | Q398 |
| Reactive lysines | K406 |
| Substrate sequence | TIGEGQQHHLGGAKQVRPE |
| Structure | 1FID |
| Surface accessibility | ASAView pdf |
| Disorder prediction | IUPred |
| Reference | PMID:2902081 |
| Notes | Q145, Q195, Q239, Q311 are minor substrate sites considering modification by TG2 |
| Template:Infobox header | | |
.png){kind=link}